TransMedics Group, Inc.: TransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ...
TransMedics says claims made by Scorpion Capital ‘have no merit’
Group addressed what we believe are inaccurate and misleading claims made in a short-seller report issued by Scorpion ...
TransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today ...
President Biden criticizes Meta's plan to end fact-checking
President Joe Biden on Friday criticized Meta Platforms' (NASDAQ:META) move to end third-party fact checking on its social ...
Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX
NDAQ:TMDX) Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX ...
Why TransMedics Group Stock Is Tanking Today
Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...
TransMedics down 10% to $65.39 after Scorpion Capital short report
EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...